|
31623.01.01
|
ALECENSA CAPS 150MG/CAP BT x 224 (4 PACKS x 56) σε PA/ALU/PVC/ALU
|
|
3.755,97 |
4.177,42 |
4.516,63 |
Roche Registration GmbH
|
|
26769.01.01
|
AVASTIN C/S.SOL.IN 100 MG/4 ML BT x 1 VIAL x 4 ML
|
|
161,05 |
185,11 |
223,69 |
Roche Registration GmbH
|
|
26769.02.01
|
AVASTIN C/S.SOL.IN 400 MG/16 ML BT x 1 VIAL x 16 ML
|
|
606,24 |
674,26 |
764,75 |
Roche Registration GmbH
|
|
22554.04.01
|
CELLCEPT C/S.SOL.IN 500MG/VIAL BTX4VIALS
|
|
21,46 |
24,66 |
33,98 |
Roche Registration GmbH
|
|
22554.01.01
|
CELLCEPT CAPS 250MG/CAP BTX100(BLIST10X10)
|
|
22,84 |
26,25 |
36,18 |
Roche Registration GmbH
|
|
22554.02.01
|
CELLCEPT F.C.TAB 500MG/TAB BTX50(BLIST5X10)
|
|
22,84 |
26,25 |
36,18 |
Roche Registration GmbH
|
|
22554.03.01
|
CELLCEPT PD.ORA.SUS 1G/5ML FLX110G
|
|
48,57 |
55,83 |
71,02 |
Roche Registration GmbH
|
|
33459.02.01
|
COLUMVI C/S.SOL.IN 10MG/VIAL BT X 1 VIAL X 10ML
|
|
3.006,59 |
3.343,94 |
3.615,47 |
Roche Registration GmbH
|
|
33459.01.01
|
COLUMVI C/S.SOL.IN 2,5MG/VIAL BT X 1 VIAL X 2.5 ML
|
|
751,75 |
836,10 |
939,45 |
Roche Registration GmbH
|
|
31293.01.01
|
COTELLIC F.C.TAB 20MG/TAB BTx63 (BLIST 3x21 δισκία) σε BLISTERS PVC/PVDC
|
|
4.148,24 |
4.613,70 |
4.988,33 |
Roche Registration GmbH
|
|
32804.01.01
|
ENSPRYNG INJ.SOL 120MG/ML 1 PF.SYR. X 1 ML
|
|
5.859,36 |
6.516,81 |
7.045,98 |
Roche Registration GmbH
|
|
30570.01.01
|
ERIVEDGE CAPS 150MG/CAP BTx28 (HDPE BOTTLE)
|
|
3.164,86 |
3.519,97 |
3.805,79 |
Roche Registration GmbH
|
|
30333.02.10
|
ESBRIET F.C.TAB 267MG/TAB 252 (84x3) δισκία σε BLISTER (PVC/Aclar(PCTFE)) - πολυσυσκευασία
|
|
1.501,56 |
1.670,05 |
1.836,64 |
Roche Registration GmbH
|
|
30333.02.09
|
ESBRIET F.C.TAB 267MG/TAB Θεραπεία έναρξης 63 (1x21 & 2x21) δισκία σε BLISTER (PVC/Aclar(PCTFE)
|
|
404,24 |
449,59 |
519,45 |
Roche Registration GmbH
|
|
30333.04.02
|
ESBRIET F.C.TAB 801MG/TAB 84 δισκία σε BLISTER (PVC/Aclar(PCTFE))
|
|
1.501,56 |
1.670,05 |
1.836,64 |
Roche Registration GmbH
|
|
32721.01.01
|
EVRYSDI PD.ORA.SOL 0,75MG/ML BT x 1 φιάλη + 1 προσαρμογέας φιάλης + 2 σύριγγες του 1ML + 2 σύριγγες των 6ML + 1 σύριγγα των 12ML
|
|
6.485,24 |
7.212,92 |
7.798,61 |
Roche Registration GmbH
|
|
26032.01.01
|
FUZEON PS.INJ.SOL 90MG/ML 60VIALS PD.FOR INJ
|
|
1.130,92 |
1.257,82 |
1.389,96 |
Roche Registration GmbH
|
|
30879.01.01
|
GAZYVARO C/S.SOL.IN 1000MG/40ML BTx1 VIAL x40ML
|
|
2.221,37 |
2.470,62 |
2.690,87 |
Roche Registration GmbH
|
|
31828.02.01
|
HEMLIBRA INJ.SOL 150MG/ML BT x 1 VIAL x 0,4 ML
|
|
4.231,11 |
4.705,97 |
5.088,09 |
Roche Registration GmbH
|
|
31828.02.02
|
HEMLIBRA INJ.SOL 150MG/ML BT x 1 VIAL x 0,7ML
|
|
7.402,88 |
8.233,72 |
8.902,30 |
Roche Registration GmbH
|
|
31828.02.03
|
HEMLIBRA INJ.SOL 150MG/ML BT x 1 VIAL x 1ML
|
|
10.574,67 |
11.761,48 |
12.716,51 |
Roche Registration GmbH
|
|
31828.01.01
|
HEMLIBRA INJ.SOL 30MG/ML BT x 1 VIAL x1 ML
|
|
2.116,49 |
2.354,03 |
2.563,89 |
Roche Registration GmbH
|
|
24573.02.01
|
HERCEPTIN INJ.SOL 600MG/5ML BTx1VIALx5ML
|
|
814,44 |
905,82 |
1.012,98 |
Roche Registration GmbH
|
|
24573.01.01
|
HERCEPTIN PD.C.SO.IN 150 MG/VIAL BTx1VIAL(GLASS)
|
|
286,90 |
319,09 |
372,06 |
Roche Registration GmbH
|
|
22874.03.01
|
INVIRASE F.C.TAB 500 mg/TAB FL x 120
|
|
172,96 |
198,81 |
240,24 |
Roche Registration GmbH
|
|
30674.01.01
|
KADCYLA PD.C.SO.IN 100MG BTx1VIAL
|
|
1.228,91 |
1.366,79 |
1.510,37 |
Roche Registration GmbH
|
|
30674.02.01
|
KADCYLA PD.C.SO.IN 160MG BTx1VIAL
|
|
1.968,00 |
2.188,83 |
2.389,76 |
Roche Registration GmbH
|
|
33087.01.01
|
LUNSUMIO C/S.SOL.IN 1MG/1ML BT X 1 VIAL X 1 ML
|
|
192,68 |
214,30 |
254,42 |
Roche Registration GmbH
|
|
33087.02.01
|
LUNSUMIO C/S.SOL.IN 30MG/30ML BT X 1 VIAL X 30 ML
|
|
5.783,10 |
6.432,00 |
6.954,28 |
Roche Registration GmbH
|
|
23564.01.01
|
MABTHERA C/S.SOL.IN 100MG/10ML VIAL BTx2VIALSx10ML
|
|
257,72 |
286,63 |
340,29 |
Roche Registration GmbH
|
|
23564.02.01
|
MABTHERA C/S.SOL.IN 500MG/50ML VIAL BTx1VIALx50ML
|
|
644,28 |
716,56 |
808,93 |
Roche Registration GmbH
|
|
23564.03.01
|
MABTHERA INJ.SOL 1400MG/11.7ML BTxVIALx15ml
|
|
1.148,69 |
1.277,58 |
1.411,79 |
Roche Registration GmbH
|
|
23564.04.01
|
MABTHERA INJ.SOL 1600MG/13.4ML BTxVIAL
|
|
1.588,46 |
1.766,70 |
1.933,57 |
Roche Registration GmbH
|
|
27904.10.01
|
MIRCERA INJ.SO.PFS 100MCG/0,3ML PF.SYR. BTx1 PF.SYR.x 0,3 ML
|
|
126,74 |
145,69 |
179,14 |
Roche Registration GmbH
|
|
27904.20.01
|
MIRCERA INJ.SO.PFS 120MCG/0,3ML PF.SYR. BTx1 PF.SYR.x 0,3 ML
|
|
143,86 |
165,36 |
199,82 |
Roche Registration GmbH
|
|
27904.11.01
|
MIRCERA INJ.SO.PFS 150MCG/0,3ML PF.SYR BTx1 PF.SYR.x 0,3 ML
|
|
176,68 |
203,09 |
241,11 |
Roche Registration GmbH
|
|
27904.12.01
|
MIRCERA INJ.SO.PFS 200MCG/0,3ML PF.SYR. BTx1 PF.SYR.x 0,3 ML
|
|
254,71 |
283,28 |
336,31 |
Roche Registration GmbH
|
|
27904.13.01
|
MIRCERA INJ.SO.PFS 250MCG/0,3ML PF.SYR. BTx1 PF.SYR.x 0,3 ML
|
|
318,19 |
353,89 |
412,64 |
Roche Registration GmbH
|
|
27904.17.01
|
MIRCERA INJ.SO.PFS 30MCG/0,3ML PF.SYR. BTx1 PF.SYR.x 0,3 ML
|
|
38,19 |
43,90 |
60,49 |
Roche Registration GmbH
|
|
27904.21.01
|
MIRCERA INJ.SO.PFS 360MCG/0,3ML PF.SYR. BTx1 PF.SYR.x 0,6 ML
|
|
461,16 |
512,89 |
587,16 |
Roche Registration GmbH
|
|
27904.08.01
|
MIRCERA INJ.SO.PFS 50MCG/0,3ML PF.SYR. BTx1 PF.SYR.x 0,3 ML
|
|
63,34 |
72,81 |
92,61 |
Roche Registration GmbH
|
|
27904.09.01
|
MIRCERA INJ.SO.PFS 75MCG/0,3ML PF.SYR. BTx1 PF.SYR.x 0,3 ML
|
|
95,04 |
109,24 |
134,32 |
Roche Registration GmbH
|
|
22896.15.02
|
NEORECORMON INJ.SO.PFS 10000 IU/0,6MLPREF.S BTx6 PREF.SYR.x0,6ML
|
|
267,46 |
297,47 |
353,16 |
Roche Registration GmbH
|
|
22896.20.02
|
NEORECORMON INJ.SO.PFS 30.000IU/0,6ML PREF.SY BTx4PF.SYR.x0,6ML
|
|
607,63 |
675,81 |
766,51 |
Roche Registration GmbH
|
|
22896.14.02
|
NEORECORMON INJ.SO.PFS 5000 IU/0,3MLPREF.SY BTx6PREF.SYR.x0,3ML
|
|
137,09 |
157,58 |
190,42 |
Roche Registration GmbH
|
|
31809.01.01
|
OCREVUS C/S.SOL.IN 300MG/VIAL BTx1 VIAL x 10ML
|
|
4.048,46 |
4.502,72 |
4.868,34 |
Roche Registration GmbH
|
|
31809.02.01
|
OCREVUS INJ.SOL 920MG/23ML (40MG/ML) BT X 1 VIAL X 23ML
|
|
9.355,06 |
10.404,76 |
11.249,63 |
Roche Registration GmbH
|
|
30484.01.01
|
PERJETA C/S.SOL.IN 420MG/VIAL (30MG/ML) BTx1 VIAL x 14ML
|
|
1.734,65 |
1.929,29 |
2.111,51 |
Roche Registration GmbH
|
|
32639.02.01
|
PHESGO INJ.SOL (1200+600)MG/VIAL 1 VIAL x 15 ML
|
|
4.276,31 |
4.756,14 |
5.142,34 |
Roche Registration GmbH
|
|
32639.01.01
|
PHESGO INJ.SOL (600+600)MG/VIAL 1 VIAL x 10 ML
|
|
2.721,03 |
3.026,34 |
3.272,08 |
Roche Registration GmbH
|
|
33863.01.01
|
PIASKY INJ.SO.INF 340MG/2ML (170MG/ML) BT X 1 ΦΙΑΛΙΔΙΟ
|
|
10.046,39 |
11.173,67 |
12.080,97 |
Roche Registration GmbH
|
|
32327.01.01
|
POLIVY PD.C.S.INF 140MG/VIAL BT x 1 VIAL
|
|
7.909,22 |
8.796,69 |
9.510,98 |
Roche Registration GmbH
|
|
32327.02.01
|
POLIVY PD.C.S.INF 30MG/VIAL BT x 1 VIAL
|
|
1.694,84 |
1.885,01 |
2.063,05 |
Roche Registration GmbH
|
|
28716.01.03
|
ROACTEMRA C/S.SOL.IN 20MG/ML BTx1 VIAL x10ML
|
|
195,37 |
217,29 |
257,96 |
Roche Registration GmbH
|
|
28716.01.05
|
ROACTEMRA C/S.SOL.IN 20MG/ML BTx1 VIAL x20ML
|
|
379,63 |
422,23 |
487,84 |
Roche Registration GmbH
|
|
28716.01.01
|
ROACTEMRA C/S.SOL.IN 20MG/ML BTx1 VIAL x4ML
|
|
78,53 |
90,27 |
114,82 |
Roche Registration GmbH
|
|
28716.03.01
|
ROACTEMRA IN.SO.PF.P 162 MG/0.9 ML BTx 4 προγεμισμένες πένες
|
|
675,57 |
751,37 |
848,22 |
Roche Registration GmbH
|
|
28716.02.01
|
ROACTEMRA INJ.SO.PFS 162mg/PF.SYR BTx4 PF.SYR
|
|
573,46 |
637,81 |
723,41 |
Roche Registration GmbH
|
|
32508.01.01
|
ROZLYTREK CAPS 100MG/CAP Φιάλη (HDPE)x30 καψάκια
|
|
672,49 |
747,95 |
844,36 |
Roche Registration GmbH
|
|
32508.02.01
|
ROZLYTREK CAPS 200MG/CAP Φιάλη (HDPE)x90 καψάκια
|
|
4.039,69 |
4.492,97 |
4.857,80 |
Roche Registration GmbH
|
|
25757.03.01
|
TAMIFLU CAPS 30MG/CAP BTx10 σε BLISTERS (PVC/PE/PVDC/ALU)
|
|
5,77 |
6,63 |
9,14 |
Roche Registration GmbH
|
|
25757.04.01
|
TAMIFLU CAPS 45MG/CAP BTx10 σε BLISTERS (PVC/PE/PVDC/ALU)
|
|
8,31 |
9,56 |
13,18 |
Roche Registration GmbH
|
|
25757.01.01
|
TAMIFLU CAPS 75MG/CAP BTx10 σε BLISTERS (PVC/PE/PVDC/ALU)
|
|
9,27 |
10,65 |
14,68 |
Roche Registration GmbH
|
|
27001.02.01
|
TARCEVA F.C.TAB 100 mg/TAB BTx 30 (BLISTER, PVC/Alu)
|
|
1.006,46 |
1.119,39 |
1.245,88 |
Roche Registration GmbH
|
|
27001.03.01
|
TARCEVA F.C.TAB 150mg/TAB BT x 30 (BLISTERS, PVC/Alu)
|
|
1.064,84 |
1.184,32 |
1.318,15 |
Roche Registration GmbH
|
|
31745.01.01
|
TECENTRIQ C/S.SOL.IN 1200MG/VIAL (20ML) 1 VIAL x 20ML
|
|
2.970,28 |
3.303,56 |
3.571,81 |
Roche Registration GmbH
|
|
31745.02.01
|
TECENTRIQ C/S.SOL.IN 840MG/VIAL (14ML) 1 VIAL x 14ML
|
|
2.074,80 |
2.307,60 |
2.513,32 |
Roche Registration GmbH
|
|
31745.03.01
|
TECENTRIQ INJ.SOL 1875MG/VIAL (15ML) BT X 1 VIAL X 15ML
|
|
3.031,53 |
3.371,68 |
3.645,46 |
Roche Registration GmbH
|
|
33162.01.01
|
VABYSMO INJ.SOL 120MG/ML BT X 1 VIAL X 0,24ML + 1 ΒΕΛΟΝΑ
|
|
587,01 |
652,88 |
740,49 |
Roche Registration GmbH
|
|
24712.01.01
|
XELODA F.C.TAB 150MG/TAB BTx60(BLIST6x10)
|
|
18,55 |
21,32 |
29,38 |
Roche Registration GmbH
|
|
32649.01.01
|
XOFLUZA F.C.TAB 20MG/TAB BTx2 δισκία σε BLISTERS OPA/φύλλο αλουμινίου/PVC
|
|
77,81 |
89,44 |
113,77 |
Roche Registration GmbH
|
|
32649.02.01
|
XOFLUZA F.C.TAB 40MG/TAB BTx2 δισκία σε BLISTERS OPA/φύλλο αλουμινίου/PVC
|
|
90,06 |
103,51 |
127,27 |
Roche Registration GmbH
|
|
30215.01.01
|
ZELBORAF F.C.TAB 240MG/TAB BTx56 (BLISTER ALU/ ALU)
|
|
1.018,88 |
1.133,21 |
1.261,26 |
Roche Registration GmbH
|
